ANDG
Andersen
ANDG has the edge over BABA overall, supported by stronger fundamentals and stronger modeled upside.
BABA
Alibaba Group Holding Limited
BABA has lower modeled downside risk, despite its lower overall score.
ANDG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
ANDG's revenue, profitability, cash flow and balance sheet are all currently healthy.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
ANDG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 29x | $65.42 | — |
| Current | 1,090x | $65.42 | — |
| Cheap | N/A | N/A | N/A |
| Fair | N/A | N/A | N/A |
| Expensive | N/A | N/A | N/A |
Historical ranges are pointers, not guarantees.
ANDG has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
ANDG Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for ANDG, with profitability holding steady. However, they disagree widely on these estimates.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over ANDG on the outlook, with more favorable profitability expectations.
ANDG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.27 | +3679% |
| Q2 2025 | $3.86 | -63% |
ANDG earned $0.06 per share over the past year, down 100% from the year before.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over ANDG in the latest year-over-year earnings comparison.
ANDG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $337.3M | +19% |
| Q2 2026 | $217.7M | +24% |
| Q1 2026 | $240.7M | +16% |
| Q4 2025 | $170.3M | +20% |
| Q3 2025 | $284.3M | +15% |
| Q2 2025 | $176M | +11% |
| Q1 2025 | $208.1M | +14% |
| Q4 2024 | $142.4M | +11% |
ANDG has the edge over BABA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | +34 points |
| Q2 2026 | -4.1% | +56 points |
| Q1 2026 | 10% | -15 points |
| Q4 2025 | 70% | +79 points |
| Q3 2025 | -3.3% | -43 points |
| Q2 2025 | -60% | -63 points |
| Q1 2025 | 25% | +3.3 points |
| Q4 2024 | -9% | +0.2 points |
ANDG has the edge over BABA on profitability, with a higher operating margin.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA's revenue has grown year over year for 16 quarters in a row: $40.2B last quarter, up 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
ANDG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $76M | +100% |
| Q2 2026 | $60.6M | +24% |
| Q1 2026 | -$7.6M | -177% |
| Q4 2025 | $76.9M | +47% |
| Q3 2025 | $38.1M | -17% |
ANDG has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
ANDG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.6x | Healthy |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | 0.1x | Very low |
ANDG's net debt is about 1.6 years of its operating earnings (EBITDA).
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA has the edge over ANDG on leverage, with a lower net debt burden relative to earnings.
ANDG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 79.0 | Overbought |
| Stochastic | 90.5 | Overbought |
ANDG's weekly RSI is 79 (overbought) and its Stochastic is 90 (overbought).
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
ANDG PE vs Consumer Cyclical Sector
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
ANDG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $60.6 | 8% above |
| 20 week MA | $53.4 | 23% above |
ANDG has stronger trend alignment. ANDG is above 2 of 2 weekly averages versus BABA above 0 of 5.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
ANDG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $24.4 | $25.4 | +3.8% |
| 2026 YTD | $25.4 | $65.4 | +158% |
ANDG has the edge over BABA on returns for 2026, with the stronger performance.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.